Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration.
Saved in:
| Title: | Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. |
|---|---|
| Authors: | Chang LK; Vitreous, Retina, Macula Consultants of New York, 460 Park Ave, Fifth Floor, New York, NY 10022, USA., Spaide RF, Brue C, Freund KB, Klancnik JM Jr, Slakter JS |
| Source: | Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2008 Jul; Vol. 126 (7), pp. 941-5. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7706534 Publication Model: Print Cited Medium: Internet ISSN: 1538-3601 (Electronic) Linking ISSN: 00039950 NLM ISO Abbreviation: Arch Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 18625940 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chang+LK%22">Chang LK</searchLink>; Vitreous, Retina, Macula Consultants of New York, 460 Park Ave, Fifth Floor, New York, NY 10022, USA.<br /><searchLink fieldCode="AU" term="%22Spaide+RF%22">Spaide RF</searchLink><br /><searchLink fieldCode="AU" term="%22Brue+C%22">Brue C</searchLink><br /><searchLink fieldCode="AU" term="%22Freund+KB%22">Freund KB</searchLink><br /><searchLink fieldCode="AU" term="%22Klancnik+JM+Jr%22">Klancnik JM Jr</searchLink><br /><searchLink fieldCode="AU" term="%22Slakter+JS%22">Slakter JS</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227706534%22">Archives of ophthalmology (Chicago, Ill. : 1960)</searchLink> [Arch Ophthalmol] 2008 Jul; Vol. 126 (7), pp. 941-5. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7706534 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-3601 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200039950%22">00039950 </searchLink><i>NLM ISO Abbreviation: </i>Arch Ophthalmol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=18625940 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/archopht.126.7.941 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 941 Titles: – TitleFull: Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chang LK – PersonEntity: Name: NameFull: Spaide RF – PersonEntity: Name: NameFull: Brue C – PersonEntity: Name: NameFull: Freund KB – PersonEntity: Name: NameFull: Klancnik JM Jr – PersonEntity: Name: NameFull: Slakter JS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2008 Jul Type: published Y: 2008 Identifiers: – Type: issn-electronic Value: 1538-3601 Numbering: – Type: volume Value: 126 – Type: issue Value: 7 Titles: – TitleFull: Archives of ophthalmology (Chicago, Ill. : 1960) Type: main |
| ResultId | 1 |
